A Study of PEG-somatropin Injection to Treat Children of Turner Syndrome

Status Recruiting

Clinical Trial Summary

This study aims to explore the optimal dose of pegylated recombinant human growth hormone (PEG-rhGH) injection to treat children of Turner syndrome (TS), preliminarily evaluate its safety and efficacy and provide scientific and reliable evidence for the medication dosage in Phase 3 clinical trial.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03189160
Study type	Interventional
Source	GeneScience Pharmaceuticals Co., Ltd.
Contact	Xiaohua Feng
Phone	0431-85170552
Email	fengxiaohua@gensci-china.com
Status	Recruiting
Phase	Phase 2
Start date	March 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01734486` - Growth Response in Girls With Turner Syndrome	Phase 4
Completed	`NCT01678261` - X-chromosome Inactivation, Epigenetics and the Transcriptome	N/A
Completed	`NCT01419249` - First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study	Phase 4
Completed	`NCT01518036` - Use of Somatropin in Turner Syndrome	Phase 3
Recruiting	`NCT04948658` - Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy
Completed	`NCT01563926` - Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency	Phase 3
Completed	`NCT02787486` - Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
Completed	`NCT00877942` - Sex Differences in Early Brain Development; Brain Development in Turner Syndrome	N/A
Completed	`NCT00825617` - Quantitative Liver Functions in Turner Syndrome With and Without Hormone Replacement Therapy	N/A
Recruiting	`NCT04463316` - GROWing Up With Rare GENEtic Syndromes
Enrolling by invitation	`NCT03836300` - Parent and Infant Inter(X)Action Intervention (PIXI)	N/A
Completed	`NCT01245374` - Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents	Phase 4
Completed	`NCT01322165` - National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions	N/A
Terminated	`NCT00419107` - Beta Cell Function in Women With Turner Syndrome	N/A
Active, not recruiting	`NCT00625001` - Long Term Follow-up of Bone Mineral Density in Hormone Treated Turner Syndrome	N/A
Completed	`NCT00029159` - The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome	Phase 3
Completed	`NCT01518062` - Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner Syndrome	Phase 4
Completed	`NCT00471731` - Dry Eye in Women With Turner Syndrome and Women With Premature Ovarian Failure	N/A
Completed	`NCT00256126` - Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN®	Phase 4
Completed	`NCT03181230` - Health, Fitness, and Quality of Life in Adolescent Girls With Turner Syndrome